The AMIGAL brand, founded in 2005 (United States), from 7 sister brands and 2214 competing brands. The AMIGAL brand is owned by Amicus Therapeutics, a company listed in New York. AMIGAL belongs to the Biotechnology business sector.

AMIGAL is a brand of Amicus Therapeutics (FOLD) Share price

Share price and profitability of the share Amicus Therapeutics (AMIGAL)

Buy Amicus Therapeutics share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 11.78

Portfolio valuation
Amicus Therapeutics (AMIGAL) over 5 years* USD 10.13

Stock market history Amicus Therapeutics (AMIGAL)

Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more